Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.11 | 0.7 |
mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.047 | 0.7 |
mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.061 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |